Literature DB >> 22571906

Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis.

N Kapur1, D Thakral, H Durgapal, S K Panda.   

Abstract

We investigated the virus-host interaction for hepatitis E virus (HEV) by performing competitive binding assays using in vitro assembled virus-like particles (VLPs). We used Escherichia coli expressed native capsid protein (pORF2) and its mutants with an attached Gly((5))-Ala (linker) reporter [enhanced green fluorescent protein (EGFP)/firefly luciferase (Fluc)]. Transmission electron microscopy and nanoparticle tracking showed near uniform particles of approximately 30-35 nm in diameter for pORF2 VLPs and 60-100 nm for reporter-linked VLPs. Binding of reporter-linked full-length (1-660aa) and N-terminal truncated (Δ1-112aa) pORF2 VLPs to Huh7 cell surfaces was found to be specific with 1.92 ± 0.065 × 10(5) sites per cell. Saturation binding indicated an equilibrium dissociation constant (K(d)) of 121.1 ± 23.83 and 123.8 ± 16.15 nm for pORF2-linker-EGFP and pORF2-linker-Fluc VLPs respectively. A similar binding pattern was observed for Δ1-112aa pORF2-linker-EGFP and Δ1-112aa pORF2-linker-Fluc VLPs with K(d) values of 123.6 ± 10.60 and 135.6 ± 16.19 nm respectively. The affinity (log K(i)) of pORF2 binding on Huh7 cells in the presence of EGFP-tagged and Fluc-tagged pORF2 VLPs was found to be approximately 2.0. However, no VLP formation or binding was observed with refolded C-terminal truncated (Δ458-660aa) pORF2. We investigated HEV internalization using fluorescent VLPs (EGFP-VLPs), which showed vesicle-mediated uptake starting at 5 min post-incubation. The uptake of VLPs could be stopped by inhibitors for clathrin-dependent endocytosis, but not by caveosome inhibitors. No binding and uptake of EGFP-VLPs were observed on non-hepatic cell lines (HeLa and SiHa). These findings suggest that HEV attaches to the host cell via a specific high affinity receptor and enters the cytoplasm by clathrin-mediated endocytosis.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22571906     DOI: 10.1111/j.1365-2893.2011.01559.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  22 in total

Review 1.  Cell Walls and the Convergent Evolution of the Viral Envelope.

Authors:  Jan P Buchmann; Edward C Holmes
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

Review 2.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

Review 3.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

Review 4.  Hepatitis E Virus Genome Structure and Replication Strategy.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

Review 5.  Therapeutic targets for the treatment of hepatitis E virus infection.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Expert Opin Ther Targets       Date:  2015-06-13       Impact factor: 6.902

6.  ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.

Authors:  Harini Sooryanarain; Adam J Rogers; Dianjun Cao; Mary Etna R Haac; Yogesh A Karpe; Xiang-Jin Meng
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

7.  Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.

Authors:  Subrat Kumar Panda; Neeraj Kapur; Daizy Paliwal; Hemlata Durgapal
Journal:  J Nanobiotechnology       Date:  2015-06-24       Impact factor: 10.435

Review 8.  Culture systems for hepatitis E virus.

Authors:  Hiroaki Okamoto
Journal:  J Gastroenterol       Date:  2012-10-27       Impact factor: 7.527

9.  C-Terminal Amino Acids 471-507 of Avian Hepatitis E Virus Capsid Protein Are Crucial for Binding to Avian and Human Cells.

Authors:  Xinquan Zhang; Ivana Bilic; Ana Marek; Martin Glösmann; Michael Hess
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

Review 10.  Role of Envelopment in the HEV Life Cycle.

Authors:  Xin Yin; Xinlei Li; Zongdi Feng
Journal:  Viruses       Date:  2016-08-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.